Skip to main contentAll experts

Leighton Elliott

AST PROF

MD-MEDICINE

  • AST PROF
    MD-MEDICINE

GRANTS

  • GRANT
    A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High-Risk RetroPeritoneal Sarcoma (STRASS 2)
    National Institute of Health Nci22 Apr 2025 - 28 Feb 2029
    Active
  • GRANT
    A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
    National Institute of Health Nci13 Jun 2024 - 28 Feb 2029
    Active
  • GRANT
    RNA-nanoparticle (RNA-NP) vaccine for ARMS
    Kate Amato Foundation1 Dec 2023 - 31 Jan 2026
    Expired
  • GRANT
    Novel RNA-Nanoparticle vaccine for treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy
    Florida Department of Health Biomed Research Pgm/J&E King30 Mar 2022 - 30 Sep 2026
    Active
  • GRANT
    Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types#
    Aveo Pharmaceuticals13 Sep 2021 - 12 Sep 2026
    Active